Patent US4732848A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4732848A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the determination of an immunologically-bindable substance involving a Fab fragment

Assignee: Roche Diagnostics GmbH
•
Filing: 1985-08-20
•
Granted: 1988-03-22
•
Expires: 2005-08-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides a process for the determination of an immunologically-bindable substance by immunochemical methods in heterogeneous phase, wherein (a) a sample solution containing the substance to be determined is incubated with (b) a solid phase-bound antibody against the bindable substance to be determined (c) a conjugate of the bindable substance to be determined and a Fab fragment of an antibody directed against a determinable enzyme in a definite amount and (d) the enzyme which corresponds to the antibody contained in the conjugate (c), the phases are separated and the enzyme activity is measured in one of the two phases. The present invention also provides a reagent for the determination of an immunologically-bindable substance, wherein it contains a solid phase-bound antibody against the bindable substance to be determined, a conjugate of the bindable substance to be determined and a Fab fragment of an antibody directed against a determinable enzyme, a determinable enzyme which binds immunologically with the Fab fragment contained in the conjugate and buffer.

Inventors

  • 👤 Helmut Lenz
  • 👤 Gerd Kleinhammer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 07:38
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; G01N33/532; G01N33/535; G01N33/563; G01N33/573

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 115 words
A process for determining an immunologically bindable substance comprising: (a) incubating a liquid sample solution containing the substance to be determined with a solid phase antibody against the bindable substance to be determined, which solid phase antibody is present in an amount insufficient to bind all of said bindable substance, a conjugate of the bindable substance to be determined and an Fab fragment of an antibody directed against a determinable enzyme, said conjugate being present in a predetermined amount and a sample of said determinable enzyme, (b) separating said solid and liquid phases, and (c) measuring the enzyme activity in one of the two phases as a measure of bindable substance in said liquid sample.
Claim 2
Dependent Claim 115 words
A process for determining an immunologically bindable substance comprising: (a) incubating a liquid sample solution containing the substance to be determined with a solid phase antibody against the bindable substance to be determined, which solid phase antibody is present in an amount insufficient to bind all of said bindable substance, a conjugate of the bindable substance to be determined and an Fab fragment of an antibody directed against a determinable enzyme, said conjugate being present in a predetermined amount and a sample of said determinable enzyme, (b) separating said solid and liquid phases, and (c) measuring the enzyme activity in one of the two phases as a measure of bindable substance in said liquid sample.
Claim 3
Dependent Claim 25 words
The process of claim 1, wherein a predetermined amount of the determinable enzyme is used and the enzyme activity is measured in the liquid phase.
Claim 4
Dependent Claim 25 words
The process of claim 1 wherein the antibody against the bindable substance is bound to the solid phase adsorptively, covalently by polymerising or by cross-linking.
Claim 5
Dependent Claim 13 words
The process of claim 1 wherein the determinable enzyme is β-galactosidase or peroxidase.
Claim 6
Dependent Claim 14 words
The process of claim 1 wherein the Fab fragment is a monoclonal Fab fragment.
Claim 7
Dependent Claim 26 words
The process of claim 1 wherein the determinable enzyme is β-galactosidase and the enzyme is determined colorimetrically using a measuring system comprising nitrophenylgalactoside, dinitrophenylgalactoside or aminophenylgalactoside.

References Cited (Backward Citations)

US3940475A Cited
DE2323467A1 Cited
DE2743444A1 Cited
US4235869A Cited
US4298593A Cited
US4361647A Cited
US4423143A Cited
US4444878A Cited
US4544640A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-03-22 1991-09-21 1992-03-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-03-22 1995-09-21 1996-03-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-03-22 1999-09-21 2000-03-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag